Join Clinical Trials
  • Login
  • Home
  • Clinical Trial Categories
  • Adults - 18 - 64
  • Kentucky


Menu

Choose Which Database to Search - Volunteer Database - Clinical Trial Database Create an Account - VOLUNTEER Accounts - RECRUITER Accounts Account Login - Volunteers Login - Recruiters Login Join a Clinical Trial Clinical Trials by Category Clinical Trials by Location Submit a Clinical Trial Frequently Asked Questions Contact Us Sitemap Blog

Categories

    Healthy Volunteers Adults - 18 - 64 Youths - Birth - 17 Seniors - 65 + Expanded Access Compensated Trials Clinical Trials by Condition Trials by Drug Type Trials for Rare Conditions

Recent Listings

  • Post your clinical trial on JoinClinicalTrials.com

    Ellijay, Georgia 30536
    United States

    Post your clinical trial on JoinClinicalTrials.com

    05-09-2019 01:01PM

JoinClinicalTrials.com

Lexington

Louisville

Owensboro

Bowling Green

Covington

Hopkinsville

Frankfort

Henderson

Richmond

Jeffersontown


Results

Post your clinical trial on JoinClinicalTrials.com
Hot

Post your clinical trial on JoinClinicalTrials.com


Ellijay, Georgia 30536
United States

Post your clinical trial on JoinClinicalTrials.com to reach thousands of viewer daily. Our Clinical Trial Listings have consistently proven to be an ...

Results 1 - 1 of 1
  • <<
  • <
  • 1
  • >
  • >>

  • Timed Exercise Study
    NCT04097886
    Condition:   Circadian Timing - Exercise
    Interventions:   Other: Morning Exercise;   Other: Evening Exercise
    Sponsor:   Julie Pendergast
    Completed
  • Trial of Neurostimulation and Blood Flow Restriction for PFPS in Active Duty
    NCT04086615
    Condition:   Patellofemoral Pain Syndrome
    Interventions:   Device: NMES and exercise supplemented with high BFR;   Device: NMES and exercise supplemented with low BFR
    Sponsors:   University of Tennessee;   Blanchfield Army Community Hospital
    Not yet recruiting
  • Neurobehavioral Mechanisms of Choice in Opioid Use Disorder
    NCT03958474
    Condition:   Opioid Use Disorder
    Intervention:   Drug: Oxycodone
    Sponsor:   Joshua A. Lile, Ph.D.
    Recruiting
  • Behavioral Effects of Drugs (Inpatient): 38
    NCT03954938
    Condition:   Cocaine Use, Unspecified
    Interventions:   Behavioral: Craving Manipulation;   Drug: Cocaine;   Drug: Placebo
    Sponsor:   William Stoops
    Recruiting
  • Suvorexant and Cocaine
    NCT03937986
    Condition:   Cocaine Use Disorder
    Interventions:   Drug: Suvorexant;   Drug: Cocaine;   Drug: Placebo oral capsule
    Sponsors:   William Stoops;   National Institute on Drug Abuse (NIDA)
    Recruiting
  • Assessment of Gut Absorption of Experimental Medication BMS-986165 in Healthy Males
    NCT03873415
    Condition:   Psoriasis
    Intervention:   Drug: BMS-986165
    Sponsor:   Bristol-Myers Squibb
    Completed
  • Transvaginal Ultrasound: Preterm Birth in Appalachia
    NCT03833284
    Condition:   Preterm Birth
    Interventions:   Behavioral: Participant Barriers to TVU Screening;   Behavioral: Provider Barriers to TVU Screening
    Sponsor:   Niraj Chavan
    Recruiting
  • Opioid and Cannabinoid Interactions
    NCT03705559
    Conditions:   Marijuana Usage;   Opioid Use
    Interventions:   Drug: Vaporized Marijuana;   Drug: Opioid Agonist
    Sponsor:   Shanna Babalonis, PhD
    Recruiting
  • Marijuana Effects on Simulated Driving Performance
    NCT03699540
    Conditions:   Cannabis;   Cannabis Use;   Marijuana;   Marijuana Usage;   Alcohol Drinking
    Interventions:   Drug: Marijuana;   Drug: Alcohol
    Sponsor:   Shanna Babalonis, PhD
    Recruiting
  • Behavioral Effects of Drugs: Inpatient (36) (Alcohol, Duloxetine, and Methylphenidate)
    NCT03575403
    Condition:   Alcohol Use Disorder
    Interventions:   Drug: Alcohol;   Drug: Placebos;   Drug: Duloxetine;   Drug: Methylphenidate
    Sponsors:   Craig Rush;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting
  • Neural Correlates of Self-regulation on Academic Functioning
    NCT03549377
    Condition:   Self-Control
    Intervention:   Behavioral: Deception
    Sponsor:   Alexander Vazsonyi
    Completed
  • Behavioral Effects of Drugs: Inpatient (35)
    NCT03519022
    Condition:   Cocaine Use Disorder
    Interventions:   Drug: Cocaine;   Drug: Placebo oral capsule;   Drug: Methylphenidate
    Sponsors:   Craig Rush;   National Institute on Drug Abuse (NIDA)
    Completed
  • Evidence-based Educational Materials and Local Resources for Improving Exercise-related Outcomes During Pregnancy
    NCT03504267
    Conditions:   Pregnancy Related;   Obesity
    Intervention:   Other: Physical Activity Education and Resources
    Sponsor:   Western Kentucky University
    Completed
  • Subacute Low Back Pain in Active Duty
    NCT03502187
    Condition:   Subacute Low Back Pain
    Interventions:   Behavioral: Progressive Exercise Plan;   Device: NeuromuscularElectricalStimulation(NMES);   Behavioral: Primary Care Management (PCM)
    Sponsors:   University of Tennessee;   Blanchfield Army Community Hospital
    Recruiting
  • Plant Exosomes and Patients Diagnosed With Polycystic Ovary Syndrome (PCOS) 17
    NCT03493984
    Condition:   Polycystic Ovary Syndrome
    Interventions:   Other: Ginger exosomes;   Other: Aloe exosomes;   Other: Placebo
    Sponsor:   University of Louisville
    Recruiting
  • To Investigate the Gastrointestinal Behaviour of Two Triple Combination Products in Healthy Male Volunteers
    NCT03415243
    Condition:   Common Cold
    Interventions:   Drug: Acetaminophen 650mg+Dextromethorphan 20mg+Phenylephrine 10mg;   Drug: Acetaminophen 325mg+Dextromethorphan 10mg+Phenylephrine 5mg
    Sponsor:   GlaxoSmithKline
    Completed
  • Exercise and Weight Control
    NCT03413826
    Conditions:   Obesity;   Exercise Reinforcement
    Intervention:   Behavioral: Exercise
    Sponsor:   University of Kentucky
    Completed
  • Influence of n-Acetylcysteine Maintenance on Alcohol Effects
    NCT03216954
    Condition:   Alcohol Use Disorder
    Interventions:   Drug: Alcohol;   Drug: Placebos;   Drug: N-acetyl cysteine
    Sponsors:   William Stoops;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting
  • Dietary Sources of Lysophospholipids
    NCT02952638
    Conditions:   Obesity;   Cardiovascular Risk Factor;   Hyperlipidemia
    Intervention:  
    Sponsor:   University of Kentucky
    Recruiting
  • Trial of Self-managed Approaches for Patellofemoral Pain Syndrome in Active Duty
    NCT02597673
    Condition:   Patellofemoral Pain Syndrome
    Interventions:   Other: Home Exercise Program (HEP);   Device: NMES;   Device: TENS
    Sponsors:   University of Tennessee;   Blanchfield Army Community Hospital
    Completed
  • Impact of Electronic Cigarettes on Perinatal Immune Responsiveness and Birth Outcomes
    NCT02553577
    Conditions:   Immune Response;   Birth Weight;   Gestational Age
    Intervention:  
    Sponsors:   Kristin Ashford;   Virginia Commonwealth University
    Recruiting
  • Reinforcing Effects of Cocaine During Phendimetrazine Maintenance
    NCT02522325
    Condition:   Cocaine Use Disorder
    Interventions:   Drug: Phendimetrazine;   Drug: Cocaine;   Drug: Placebo
    Sponsors:   William Stoops;   National Institute on Drug Abuse (NIDA)
    Completed
  • Topiramate-Phentermine Combinations for Cocaine Dependence
    NCT02239913
    Condition:   Cocaine Use Disorder
    Interventions:   Drug: Cocaine;   Drug: Placebo;   Drug: Phentermine;   Drug: Topiramate
    Sponsors:   University of Kentucky;   National Institute on Drug Abuse (NIDA)
    Completed
  • Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine]
    NCT04178993
    Condition:   Methamphetamine Use Disorder
    Interventions:   Drug: Methamphetamine;   Drug: Methylphenidate;   Drug: Placebo oral capsule;   Drug: Duloxetine
    Sponsors:   Craig Rush;   National Institute on Drug Abuse (NIDA)
    Recruiting
  • Depression, Trauma, and Health: Efficacy of an mHealth App for Symptom Self-Management in College Students
    NCT04094792
    Condition:   Depression
    Intervention:   Device: Happify Breather App
    Sponsors:   University of Kentucky;   Happify Inc.
    Recruiting
  • Personalized Treatment
    NCT04183894
    Conditions:   Eating Disorders;   Eating Disorder Symptom
    Intervention:   Behavioral: Personalized Intervention
    Sponsor:   University of Louisville
    Recruiting
  • Kentucky Communities and Researchers Engaging to Halt the Opioid Epidemic (CARE2HOPE)
    NCT04134767
    Conditions:   Substance Use;   HIV Infections;   HCV Infection;   Sexually Transmitted Infections (Not HIV or Hepatitis);   Overdose, Drug;   Opioid Use
    Interventions:   Behavioral: Re-entry Health Linkage;   Behavioral: Overdose Education
    Sponsors:   University of Kentucky;   National Institute on Drug Abuse (NIDA);   Substance Abuse and Mental Health Services Administration (SAMHSA);   Emory University;   Temple University
    Not yet recruiting
  • Diagnosis of ON With or Without MS or NMOSD
    NCT04131764
    Conditions:   Multiple Sclerosis;   Neuromyelitis Optica Spectrum Disorder Attack;   Neuromyelitis Optica Spectrum Disorder Relapse;   Neuromyelitis Optica Spectrum Disorder Progression;   Optic Neuritis
    Intervention:   Diagnostic Test: Reflex (Brightlamp Inc., Purdue University)
    Sponsor:   University of Kentucky
    Enrolling by invitation
  • MS and NMOSD in African-Americans
    NCT04131673
    Conditions:   Multiple Sclerosis;   Neuromyelitis Optica
    Intervention:  
    Sponsor:   University of Kentucky
    Enrolling by invitation
  • Standing, Stepping and Voluntary Movement Spinal Cord Epidural Stimulation
    NCT04123847
    Condition:   Spinal Cord Injuries
    Interventions:   Other: Standing and Stepping;   Device: Standing, Stepping and Voluntary Movement with spinal cord Epidural Stimulation
    Sponsors:   Susan Harkema;   The Leona M. and Harry B. Helmsley Charitable Trust
    Recruiting
  • Internet Auditory Rehabilitation: Follow-up to Adult Hearing Screening
    NCT04122183
    Condition:   Hearing Loss
    Intervention:   Other: iManage (my hearing loss)
    Sponsors:   University of Louisville;   William Demant Foundation (Formerly known as the Oticon Foundation)
    Not yet recruiting
  • Gastric Electrical Stimulation for Abdominal Pain in Gastroparesis
    NCT04121325
    Condition:   Abdominal Pain
    Intervention:   Device: Enterra
    Sponsor:   University of Louisville
    Not yet recruiting
  • Intra-operative Fraction of Inspired Oxygen and Lung Injury in Coronary Artery Bypass Grafting Surgery
    NCT04115501
    Conditions:   Lung Injury;   Pulmonary Complication
    Intervention:   Other: Fraction of Inspired Oxygen
    Sponsors:   University of Louisville;   Peking Union Medical College Hospital;   Tianjin Chest Hospital;   Xiangya Hospital of Central South University;   Guangdong Provincial People's Hospital;   Second Xiangya Hospital of Central South University;   Peking University People's Hospital
    Not yet recruiting
  • Transformation of Paralysis to Stepping
    NCT04105114
    Condition:   Spinal Cord Injuries
    Interventions:   Drug: Buspirone;   Device: Non-invasive Spinal Cord Stimulation;   Device: Ekso Bionics Exoskeleton;   Device: Gravity Neutral Device;   Device: Body Weight Supported Treadmill Training;   Device: Rolling Walker
    Sponsor:   University of Louisville
    Not yet recruiting
  • Xoft® Intraoperative Radiotherapy (IORT) for Patients With Early-Stage Breast Cancer
    NCT04088435
    Conditions:   Breast Cancer;   Breast Cancer, Invasive Ductal;   Invasive Mammary Carcinoma;   Breast Cancer Stage I;   Breast Cancer Stage IIA
    Intervention:   Radiation: Intraoperative radiotherapy
    Sponsor:   University of Louisville
    Recruiting
  • Sodium Watchers Program - Hypertension
    NCT04076280
    Condition:   Hypertension
    Interventions:   Behavioral: Sodium Watcher Program-Hypertension;   Behavioral: Usual Care
    Sponsor:   Misook L. Chung
    Recruiting
  • A (Prospective/Pilot) Study Evaluating the Effect of Cataract Surgery on the Daily Activity Levels of Elderly Patients
    NCT04074954
    Conditions:   Cataract;   Diabetes;   Hypertension;   Obesity;   Vision Disability
    Intervention:   Procedure: Cataract surgery
    Sponsor:   University of Pikeville
    Recruiting
  • Redefining Survivorship: POWER to Maximize Physical Function for Survivors of Critical Illness
    NCT04058977
    Conditions:   Critical Illness;   Muscle Atrophy or Weakness
    Intervention:   Other: Power training
    Sponsors:   University of Kentucky;   Nathan Johnson, PT, PhD;   Ashley Montgomery-Yates, MD;   Amy Pastva, PT, PhD;   Peter E. Morris, MD
    Not yet recruiting
  • Study of Intraoperative Radiotherapy for Patients With Large Brain Metastases Treated With Neurosurgical Resection
    NCT04040400
    Condition:   Brain Metastases
    Intervention:   Device: intraoperative radiotherapy (IORT)
    Sponsor:   University of Louisville
    Recruiting
  • A Study to Evaluate the Safety and Effectiveness Assessments of Restylane-Defyne for Punctual Occlusion
    NCT04022382
    Condition:   Dry Eye
    Intervention:   Device: Restylane Defyne
    Sponsor:   John C Meyer, MD
    Completed
  • Total Knee Replacement With Tourniquet or Aquamantys
    NCT04016285
    Condition:   Knee Replacement
    Interventions:   Device: Aquamantys;   Device: Tourniquet
    Sponsors:   Stephen Duncan;   Medtronic
    Recruiting
  • Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer
    NCT04011410
    Condition:   Prostate Cancer Recurrent
    Intervention:   Drug: Hydroxychloroquine Sulfate 200Mg Tab
    Sponsor:   University of Kentucky
    Not yet recruiting
  • Testing a Smart Phone App to Enhance Voice Therapy Adherence
    NCT04002336
    Condition:   Voice Disorders
    Interventions:   Behavioral: Traditional Voice therapy;   Behavioral: Voice Therapy App
    Sponsor:   Vrushali Angadi
    Completed
  • Effects of 5HTP and LDOPA on CNS Excitability After SCI
    NCT04000919
    Condition:   Spinal Cord Injuries
    Interventions:   Drug: 5HTP;   Drug: L-DOPA;   Drug: Placebo oral tablet;   Drug: Carbidopa
    Sponsor:   Jessica M D'Amico
    Recruiting
  • Non-Invasive Spinal Cord Stimulation After Injury
    NCT03998527
    Condition:   Spinal Cord Injuries
    Intervention:   Device: Transcutaneous Electrical Spinal Cord Stimulation (TcESCS)
    Sponsor:   University of Louisville
    Recruiting
  • Study of Lumbar Discectomy With Annular Closure
    NCT03986580
    Condition:   Lumbar Disc Herniation
    Intervention:   Device: BARRICAID device
    Sponsor:   Intrinsic Therapeutics
    Not yet recruiting
  • Study of Regional Cerebral Oxygenation and Brain Blood Volume Changes During Carotid Endarterectomy Using the NeurOS System
    NCT03981757
    Condition:   Carotid Disease
    Intervention:   Device: NeurOS
    Sponsor:   University of Louisville
    Recruiting
  • Regional Cerebral Oxygenation and Brain Blood Volume During Cardiac Surgery Using the NeurOS System
    NCT03969836
    Condition:   Heart Diseases
    Intervention:   Device: NeurOS system
    Sponsor:   University of Louisville
    Recruiting
  • Combination Rucaparib With Nivolumab in Small Cell Lung Carcinoma
    NCT03958045
    Condition:   Small Cell Lung Cancer
    Intervention:   Combination Product: Rucaparib and Nivolumab
    Sponsor:   Aman Chauhan
    Recruiting
  • Improving Hand Recovery With Neuromodulation in Tetraplegia
    NCT03954496
    Conditions:   Spinal Cord Injuries;   Tetraplegia, Unspecified, Incomplete, Chronic
    Interventions:   Device: transcranial direct current stimulation;   Behavioral: Intensive upper extremity motor training
    Sponsors:   University of Kentucky;   Wings for Life - spinal cord research foundation
    Recruiting
  • Better Together: A Web-based Relationship Education Tool
    NCT03953495
    Condition:   Same-Sex Relationships
    Interventions:   Behavioral: Better Together;   Behavioral: Better Together (delayed)
    Sponsor:   Sharon Scales Rostosky
    Recruiting
  • The Kentucky Viral Hepatitis Treatment Study
    NCT03949764
    Conditions:   Hepatitis C;   Opioid-Related Disorders;   Injection Drug Use
    Intervention:   Drug: Sofosbuvir/velpatasvir (Epclusa®)
    Sponsors:   Jennifer Havens;   National Institute on Drug Abuse (NIDA);   National Cancer Institute (NCI);   Gilead Sciences;   University of Kentucky;   Icahn School of Medicine at Mount Sinai;   University of Bristol
    Not yet recruiting
  • Tourniquet vs. Short Time Tourniquet in Primary Robotic Assisted TKA
    NCT03942939
    Condition:   Knee Arthropathy
    Interventions:   Other: Primary Robotic-Assisted Total Knee Arthroplasty with a short tourniquet time;   Other: Primary Robotic-Assisted Total Knee Arthroplasty with the use of a tourniquet
    Sponsor:   University of Louisville
    Recruiting
  • DUR-928 in Patients With Alcoholic Hepatitis
    NCT03917407
    Condition:   Alcoholic Hepatitis
    Interventions:   Drug: DUR-928 (Moderate AH);   Drug: DUR-928 (Severe AH)
    Sponsors:   Craig James McClain;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting
  • Durvalumab and Tremelimumab Combination in Somatically Hypermutated Recurrent Solid Tumors
    NCT03911557
    Condition:   Tumor, Solid
    Intervention:   Drug: Durvalumab and Tremelimumab
    Sponsor:   John L. Villano, MD, PhD
    Recruiting
  • Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal Women
    NCT03854396
    Conditions:   Recurrent Urinary Tract Infection;   Postmenopause;   Postmenopausal Syndrome;   Postmenopausal Symptoms;   Menopause
    Interventions:   Drug: Prasterone;   Drug: Placebo
    Sponsors:   Olivia Cardenas-Trowers, M.D.;   AMAG Pharmaceuticals, Inc.
    Not yet recruiting
  • Intraoral Administration of Botox in Patients With Dentoalveolar Neuropathic Pain
    NCT03848143
    Condition:   Neuropathic Pain
    Intervention:   Drug: onabotulinum toxin A
    Sponsors:   Isabel Moreno Hay;   Allergan Sales, LLC
    Recruiting
  • ACB + IPACK Block With or Without Local Infiltration in RA-TKA
    NCT03840122
    Condition:   Knee Arthropathy
    Interventions:   Other: ACB + IPACK block with injection of local anesthetic;   Other: ACB + IPACK block without injection
    Sponsor:   University of Louisville
    Withdrawn
  • Dietary Intervention in Persons With Metabolic Syndrome
    NCT03836651
    Condition:   Metabolic Syndrome
    Interventions:   Other: Dietary Antioxidant (V8® Low Sodium 100% vegetable juice);   Other: Control group
    Sponsor:   Martha Biddle
    Recruiting
  • Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patients With a New Diagnosis
    NCT03742661
    Condition:   Epilepsy
    Intervention:   Device: SPEAC System
    Sponsor:   Brain Sentinel
    Active, not recruiting
  • Inflammatory Markers in Trauma Patient Outcomes
    NCT03671746
    Condition:   Polytrauma
    Interventions:   Drug: Ketorolac;   Drug: Saline Solution
    Sponsor:   Arun Aneja
    Recruiting
  • Retrospective Analysis on Distal Humerus Fractures
    NCT03637621
    Condition:   Distal Humerus Fracture
    Intervention:   Other: ORIF
    Sponsor:   The Orthopaedic Research & Innovation Foundation
    Active, not recruiting
  • Reverse Total Shoulder Arthroplasty: A Data Analysis on Patients Undergoing Reverse Total Shoulder Arthroplasty
    NCT03617107
    Conditions:   Osteo Arthritis Shoulders;   Proximal Humeral Fracture;   Rotator Cuff Tear;   Rotator Cuff Tear Arthropathy
    Intervention:   Other: reverse total shoulder arthroplasty
    Sponsor:   The Orthopaedic Research & Innovation Foundation
    Active, not recruiting
  • Does Depth of Neuromuscular Blockade (NMB) Affect Surgical Conditions in Obese Patients Undergoing Robotic Surgery
    NCT03591289
    Conditions:   GYN Disorders;   Urologic Diseases
    Intervention:   Drug: NMB with rocuronium bromide
    Sponsor:   Rainer Lenhardt
    Recruiting
  • Community Access, Retention in Care, and Engagement for Hepatitis C Treatment
    NCT03581383
    Condition:   Hepatitis C
    Interventions:   Behavioral: PREP-C;   Behavioral: Modified ECHO
    Sponsor:   Jens Rosenau
    Recruiting
  • Building Stronger Allies
    NCT03571750
    Conditions:   Suicide;   Risk Reduction
    Interventions:   Behavioral: Building Stronger Allies;   Behavioral: Health Education Training
    Sponsor:   Florida State University
    Recruiting
  • A Review of Low-Dose CT Lung Cancer Screenings in a Community-Based Healthcare System With High Incidence
    NCT03560791
    Condition:   Non-small Cell Lung Cancer
    Intervention:  
    Sponsor:   St Elizabeth Healthcare
    Enrolling by invitation
  • Effects of Family Sodium Watcher Program on Outcomes in Heart Failure Patient-Family Caregiver Dyads
    NCT03560206
    Condition:   Heart Failure
    Interventions:   Behavioral: Family SWaP intervention with mini iPad;   Behavioral: usual care
    Sponsor:   Misook L. Chung
    Active, not recruiting
  • An Analysis of Treatment Timelines for Lung Cancer Patients Across System Evolutions
    NCT03535766
    Condition:   Lung Cancer
    Intervention:  
    Sponsor:   St Elizabeth Healthcare
    Enrolling by invitation
  • Teachable Moment Brief Intervention for Veterans Following a Suicide Attempt
    NCT03533075
    Condition:   Suicide, Attempted
    Intervention:   Behavioral: Teachable Moment Brief Intervention
    Sponsors:   Louisville VA Medical Center;   University of Louisville
    Active, not recruiting
  • Idiopathic Parkinson's Progression and Dopamine Transporter SPECT
    NCT03531086
    Condition:   Parkinson Disease
    Intervention:   Drug: Ioflupane I 123
    Sponsor:   Julie Gurwell
    Active, not recruiting
  • Tanglewood Trail Walking Program in Rural Kentucky
    NCT03495648
    Condition:   Dietary Habits
    Interventions:   Behavioral: walking group led by a community organizer;   Behavioral: Drive
    Sponsors:   Dawn Brewer;   National Institute of Environmental Health Sciences (NIEHS)
    Active, not recruiting
  • BerryCare: A Community Engagement Program
    NCT03477305
    Condition:   Cardiovascular Risk Factor
    Intervention:   Behavioral: Blackberry Consumption
    Sponsors:   Dawn Brewer;   National Institute of Environmental Health Sciences (NIEHS)
    Completed
  • Clinic to Community Navigation to Improve Diabetes Outcomes
    NCT03474731
    Condition:   Diabetes Mellitus
    Interventions:   Behavioral: Diabetes Self Management Program;   Behavioral: Tailored Patient Navigation (PN) only;   Behavioral: DSMP AND Tailored Patient Navigation
    Sponsor:   Nancy Schoenberg
    Recruiting
  • Social Media HIV Prevention Intervention for High Risk Rural Women
    NCT03456453
    Condition:   HIV/AIDS
    Intervention:   Behavioral: NIDA Standard for HIV Prevention
    Sponsors:   University of Kentucky;   National Institute on Drug Abuse (NIDA)
    Recruiting
  • SPARC Bladder Mapping and Training Study
    NCT03452007
    Condition:   Spinal Cord Injuries
    Intervention:   Device: Epidural Stimulation
    Sponsor:   University of Louisville
    Recruiting
  • Re-entry XR-NTX for Rural Women With Opioid Use Disorder
    NCT03447743
    Condition:   Opioid Dependence
    Intervention:   Drug: XR-NTX community location
    Sponsor:   University of Kentucky
    Recruiting
  • "Assessment of the Quality and Quantity of Bone Regeneration."
    NCT03417375
    Condition:   Bone Quality and Quantity
    Intervention:   Procedure: Bilateral Sinus Augmentation
    Sponsor:   University of Kentucky
    Active, not recruiting
  • Chemotherapy-Induced Cognitive Impairment in Ovarian Cancer Patients
    NCT03324945
    Condition:   Chemotherapy-induced Cognitive Impairment
    Intervention:   Behavioral: Neurocognitive assessments
    Sponsors:   University of Kentucky;   Office of US Army Medical Research and Material Command
    Active, not recruiting
  • Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
    NCT03321656
    Condition:   End Stage Renal Disease
    Interventions:   Drug: Tacrolimus;   Drug: Envarsus XR
    Sponsors:   Roberto Gedaly;   Veloxis Pharmaceuticals
    Recruiting
  • Consultation, Advice, and Tailored Support (CATS) for Cancer Survivors
    NCT03316170
    Conditions:   Smoking Cessation;   Social Stress
    Interventions:   Behavioral: Social Support;   Drug: NRT Sampling
    Sponsors:   Jessica Burris;   Kentucky Lung Cancer Research Program
    Recruiting
  • Priming Immunotherapy in Advanced Disease With Radiation
    NCT03313804
    Conditions:   Non-small Cell Lung Cancer;   Squamous Cell Carcinoma of the Head and Neck
    Interventions:   Drug: Immune checkpoint inhibitor;   Radiation: Radiation Therapy
    Sponsor:   John L. Villano, MD, PhD
    Recruiting
  • Dysregulated CNS Inflammation After Acute Brain Injury
    NCT03287557
    Conditions:   Traumatic Brain Injury;   Aneurysmal Subarachnoid Hemorrhage
    Intervention:  
    Sponsor:   University of Kentucky
    Completed
  • A Pilot Study Using Autologous Regulatory T Cell Infusion Zortress (Everolimus) in Renal Transplant Recipients
    NCT03284242
    Conditions:   End Stage Renal Disease;   Kidney Transplant
    Intervention:   Procedure: Apheresis
    Sponsors:   Roberto Gedaly;   Novartis Pharmaceuticals
    Recruiting
  • Cocaine Use Reduction and Health
    NCT03224546
    Condition:   Cocaine Use Disorder
    Intervention:   Behavioral: Contingency Management
    Sponsors:   William Stoops;   National Institute on Drug Abuse (NIDA)
    Recruiting
  • Intraoperative Amiodarone to Prevent Atrial Fibrillation in Lung Transplant Patients
    NCT03221764
    Conditions:   Atrial Fibrillation;   Lung Transplant; Complications
    Interventions:   Drug: Amiodarone with CoSeal;   Device: CO2 driver
    Sponsor:   University of Louisville
    Completed
  • Blood And Clot Thrombectomy Registry And Collaboration
    NCT03153683
    Condition:   Acute Ischemic Stroke
    Intervention:   Other: Registry
    Sponsors:   Justin Fraser;   University of Kentucky
    Recruiting
  • Vitamin D for Muscle Metabolic Function in Cancer Cachexia
    NCT03144128
    Conditions:   Cancer Cachexia;   Vitamin D Deficiency
    Interventions:   Dietary Supplement: Vitamin D;   Dietary Supplement: Placebo
    Sponsor:   David Travis Thomas
    Recruiting
  • Apolipoprotein E (ApoE) and Metabolism
    NCT03109561
    Conditions:   Cognitive Function;   Healthy
    Interventions:   Other: Resting State Indirect Calorimetry;   Genetic: ApoE;   Diagnostic Test: Metabolism;   Other: Cognitive Challenge
    Sponsor:   Lance Johnson
    Recruiting
  • Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
    NCT03089554
    Condition:   Cancer
    Intervention:   Drug: Therapeutic Intervention
    Sponsor:   Rachel Miller
    Recruiting
  • Video-Laryngoscope Alone or With Bronchoscope for Predicted Difficult Intubation
    NCT03080896
    Condition:   Intubation; Difficult
    Interventions:   Device: King Vision video-laryngoscope with #3 disposable blade and endotracheal tube stylet;   Device: fiberoptic bronchoscope aScope III
    Sponsors:   University of Louisville;   Ambu A/S
    Recruiting
  • Rural Intervention for Caregivers' Heart Health
    NCT03068390
    Condition:   Cardiovascular Risk Factor
    Interventions:   Behavioral: RICHH Intervention;   Behavioral: Usual care
    Sponsors:   Debra Moser;   National Institute of Nursing Research (NINR)
    Recruiting
  • Recovery of Bladder and Sexual Function After Spinal Cord Injury
    NCT03036527
    Condition:   Spinal Cord Injuries
    Interventions:   Procedure: Activity-based locomotor training;   Procedure: Activity-based stand training;   Procedure: Activity-based upper arm ergometry
    Sponsor:   University of Louisville
    Recruiting
  • Biological Effects of Agent on PAR-4 Levels With Resected Solid Tumors
    NCT03015324
    Condition:   Solid Tumor
    Intervention:   Drug: Hydroxychloroquine
    Sponsor:   Peng Wang, MD PhD
    Recruiting
  • Fosbretabulin With Everolimus in Neuroendocrine Tumors With Progression
    NCT03014297
    Conditions:   Neuroendocrine Tumors;   Everolimus
    Interventions:   Drug: everolimus;   Drug: fosbretabulin
    Sponsor:   Lowell Anthony, MD
    Terminated
  • Impact of an Intensive Monitoring Strategy in Symptomatic Patients With Suspected Arrhythmia
    NCT03001765
    Condition:   Suspected Arrhythmia
    Intervention:   Other: Intensive Monitoring Strategy: Reveal LINQ™ Insertable Cardiac Monitoring System".
    Sponsor:   St Elizabeth Healthcare
    Completed
  • Cisplatin + Radiation in SCCHN and Correlation With Oxidative Stress Markers
    NCT02994069
    Conditions:   Carcinoma, Squamous Cell;   Head and Neck Cancer
    Interventions:   Drug: Cisplatin;   Radiation: XRT
    Sponsor:   Susanne Arnold
    Recruiting
  • Electronic Decision Support for Intervention in Poorly Controlled Type 2 Diabetes
    NCT02924207
    Condition:   Diabetes Mellitus
    Intervention:   Other: PATH electronic decision support tool
    Sponsors:   St Elizabeth Healthcare;   PATH Decision Support Software, LLC
    Completed
  • Low Sodium vs. Regular Diet in Patients Admitted for Heart Failure
    NCT02689635
    Condition:   Heart Failure
    Interventions:   Other: Sodium Restricted Diet;   Other: Regular Diet
    Sponsor:   Maya Guglin
    Recruiting
  • Percutaneous Nerve Evaluation With Fluoroscopy Versus Without
    NCT02677753
    Conditions:   Overactive Bladder;   Urinary Incontinence;   Fecal Incontinence
    Intervention:   Radiation: Fluoroscopy
    Sponsor:   University of Louisville
    Completed
  • Achieving Patient-Centered Care and Optimized Health In Care Transitions by Evaluating the Value of Evidence
    NCT02354482
    Condition:   Care Transitions
    Interventions:   Behavioral: Patient Communication and Care Management;   Behavioral: Home-Based Trust, Plain Language, and Coordination;   Behavioral: Hospital-Based Trust, Plain Language, and Coordination;   Behavioral: Patient/Caregiver Assessment and Provider Information Exchange;   Behavioral: Assessment and Teach Back;   Other: Standard of Care (Reference)
    Sponsors:   Mark Williams;   University of Pennsylvania;   Boston Medical Center;   Westat;   Kaiser Permanente;   Telligen, Inc.;   University of Illinois at Chicago;   Hospital Research & Education Trust, American Hospital Association;   Joint Commission Resources;   America's Essential Hospitals;   Louisiana State University Health Sciences Center Shreveport;   United Hospital Fund;   Caregiver Action Network;   National Association of Area Agencies on Aging
    Completed
  • Epi Stim to Facilitate Standing and Stepping
    NCT02339233
    Condition:   Spinal Cord Injury
    Intervention:   Device: Standing and Stepping with spinal cord Epidural Stimulation
    Sponsors:   University of Louisville;   University of California, Los Angeles;   Christopher Reeve Paralysis Foundation;   Kessler Foundation;   The Leona M. and Harry B. Helmsley Charitable Trust;   National Institute for Biomedical Imaging and Bioengineering (NIBIB)
    Completed
  • Effect of All-Stim 2 Quadriceps Treatments on Limb Muscle Strength In Mechanically Ventilated Patients
    NCT02332187
    Condition:   Weakness
    Interventions:   Device: Active electrical stimulation using an All Stim stimulator;   Device: Sham electrical stimulation using an All Stim stimulator
    Sponsor:   Gerald Supinski
    Recruiting
  • Sildenafil in Heart Failure With Reactive Pulmonary Hypertension
    NCT02304705
    Condition:   Heart Failure With Reactive Pulmonary Hypertension
    Interventions:   Drug: Sildenafil;   Drug: Placebo
    Sponsor:   Maya Guglin
    Terminated
  • Transcutaneous Spinal Stimulation: Safety and Feasibility for Upper Limb Function in Children With Spinal Cord Injury
    NCT04032990
    Condition:   Spinal Cord Injuries
    Intervention:   Device: Biostim-5 transcutaneous spinal stimulator
    Sponsors:   University of Louisville;   The Jewish Heritage Foundation for Excellence
    Not yet recruiting
  • HCQ on PAR-4 Levels in Patients With Resectable Solid Tumors
    NCT02232243
    Condition:   Solid Tumor
    Interventions:   Drug: Hydroxychloroquine, 200mg twice dailiy;   Drug: Hydroxychloroquine, 400mg twice daily
    Sponsor:   Peng Wang, MD PhD
    Completed
  • A Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHN
    NCT02126969
    Conditions:   Head and Neck Cancer;   Larynx
    Interventions:   Radiation: Low dose fractionated radiation - 80cGy with chemotherapy;   Drug: Docetaxel and Carboplatin AUC 6
    Sponsor:   University of Kentucky
    Active, not recruiting
  • Blood Lipopolysaccharide (LPS) Rifaximin Study
    NCT02124512
    Conditions:   Obese;   Insulin Resistance;   Metabolic Syndrome
    Interventions:   Drug: Rifaximin SSD;   Other: Placebo
    Sponsors:   Philip Kern;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
    Completed
  • Randomized Study of Beet Root in Locally Advanced Squamous Cell Cancer of the Head and Neck
    NCT02058849
    Condition:   Mucositis
    Interventions:   Drug: Beetroot;   Other: Placebo
    Sponsor:   David Travis Thomas
    Completed
  • Cohort 2 Efficacy of Nasopharyngeal Ventilation With Endotracheal Tube for Surgery
    NCT02018146
    Condition:   General Anesthesia With Endotracheal Intubation in Surgery
    Interventions:   Other: Mask then nasopharyngeal;   Other: Nasopharyngeal then mask
    Sponsor:   University of Louisville
    Completed
  • Early Detection and Prevention of Mild Cognitive Impairment Due to Cerebrovascular Disease
    NCT01924312
    Conditions:   Cerebrovascular Disease;   Mild Cognitive Impairment
    Intervention:   Behavioral: Heart Health Intervention
    Sponsor:   Gregory Jicha, 323-5550
    Completed
  • Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung Cancers
    NCT01871454
    Condition:   Non-small Cell Lung Cancers
    Interventions:   Radiation: stereotactic ablative radiotherapy (SABR);   Drug: Pentoxifylline
    Sponsors:   University of Louisville;   James Graham Brown Cancer Center
    Recruiting
  • Early Anti-inflammatory Treatment in Patients With Acute ACL Tear and Painful Effusions
    NCT03429140
    Condition:   Anterior Cruciate Ligament
    Interventions:   Drug: Gel-One;   Other: Saline Placebo
    Sponsor:   Mary Ireland
    Active, not recruiting
  • Brief Intervention for Rural Women at High Risk for HIV/HCV
    NCT01840722
    Conditions:   Acquired Immune Deficiency Syndrome Virus;   Hepatitis C;   Drug Abuse
    Intervention:   Other: MI-based HIV Risk Reduction
    Sponsors:   Michele Staton;   National Institute on Drug Abuse (NIDA)
    Completed
  • Overcoming Chemotherapy Resistance In Refractory Multiple Myeloma With Simvastatin and Zoledronic Acid
    NCT01772719
    Condition:   Multiple Myeloma
    Intervention:   Drug: Simvastatin and zoledronic acid
    Sponsors:   University of Louisville;   James Graham Brown Cancer Center
    Terminated
  • Study of Lung Cancer in Appalachian Kentucky: The Role of Environmental Carcinogens
    NCT01648166
    Condition:   Lung Cancer
    Intervention:   Other: Environmental sampling
    Sponsors:   Susanne Arnold;   United States Department of Defense
    Completed
  • IL-1RA Treatment in Patients With Acute ACL Tear and Painful Effusions
    NCT02930122
    Condition:   Anterior Cruciate Ligament Tear
    Interventions:   Drug: Saline (0.9%) and anakinra (150mg);   Drug: anakinra (150mg) and Saline (0.9%);   Other: Saline intraarticularly
    Sponsors:   Cale Jacobs, PhD;   Arthritis Foundation
    Recruiting
  • A Feasibility Study Using Four-Dimensional CT Imaging for Primary Lung Cancer
    NCT01500876
    Condition:   Lung Cancer
    Intervention:   Radiation: 4D-CT pre-treatment scan
    Sponsors:   University of Louisville;   James Graham Brown Cancer Center
    Active, not recruiting
  • Accelerated Hypofractionated Radiotherapy (AHF-RT) for the Treatment of Breast Cancer
    NCT01278212
    Condition:   Breast Cancer
    Intervention:   Radiation: accelerated hypofractionated radiotherapy (AHF-RT)
    Sponsors:   University of Louisville;   James Graham Brown Cancer Center
    Active, not recruiting
  • The Effect of Beta-glucan in Non-Small Cell Lung Cancer
    NCT00682032
    Condition:   Non Small Cell Lung Cancer
    Intervention:   Dietary Supplement: beta-glucan
    Sponsors:   University of Louisville;   James Graham Brown Cancer Center
    Recruiting
  • Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)
    NCT00673439
    Condition:   Heparin-Induced Thrombocytopenia
    Interventions:   Drug: fondaparinux;   Drug: warfarin
    Sponsors:   University of Louisville;   James Graham Brown Cancer Center
    Terminated
  • Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate Cancer
    NCT00456989
    Condition:   Prostate Cancer
    Interventions:   Drug: Taxotere;   Drug: Doxil
    Sponsors:   University of Louisville;   James Graham Brown Cancer Center
    Completed
  • Prognostic Markers of Gynecologic Cancers
    NCT00290459
    Conditions:   Gynecologic Disease;   Gynecologic Cancer
    Intervention:  
    Sponsors:   University of Louisville;   James Graham Brown Cancer Center
    Recruiting
  • Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer
    NCT02128100
    Condition:   Pancreatic Cancer Non-resectable
    Interventions:   Drug: Folfirinox;   Radiation: Stereotactic Body Radiation Therapy
    Sponsors:   University of Louisville;   James Graham Brown Cancer Center
    Recruiting
  • Epicutaneous Cryoimmunotherapy Combined With Pembrolizumab for Cutaneous Metastatic Breast Cancer
    NCT03982004
    Condition:   Metastatic Breast Cancer
    Interventions:   Device: Epicutaneous cryoimmunotherapy;   Drug: Topical imiquimod;   Drug: Pembrolizumab;   Other: Dermatologic Quality of Life Index;   Other: Functional Assessment of Cancer Therapy;   Drug: Intra-lesional GM-CSF;   Device: Cry-AC
    Sponsors:   Washington University School of Medicine;   Merck Sharp & Dohme Corp.
    Not yet recruiting
  • Comparative Effectiveness of IIMR to the CDSMP
    NCT03966872
    Conditions:   Mental Illness;   Chronic Disease
    Interventions:   Behavioral: Integrated Illness Management and Recovery;   Behavioral: Chronic Disease Self-Management Program
    Sponsors:   Dartmouth-Hitchcock Medical Center;   Patient-Centered Outcomes Research Institute
    Recruiting
  • Glutaminase Inhibitor CB-839 Hydrochloride and Osimertinib in Treating Patients With EGFR-Mutated Stage IV Non-small Cell Lung Cancer
    NCT03831932
    Conditions:   Advanced Lung Non-Small Cell Carcinoma;   Metastatic Lung Non-Small Cell Carcinoma;   Stage IV Lung Cancer AJCC v8;   Stage IVA Lung Cancer AJCC v8;   Stage IVB Lung Cancer AJCC v8
    Interventions:   Drug: Glutaminase Inhibitor CB-839;   Drug: Glutaminase Inhibitor CB-839 Hydrochloride;   Drug: Osimertinib
    Sponsor:   National Cancer Institute (NCI)
    Recruiting
  • Post-Market Study of Comprehensive Reverse Augmented Glenoid and Mini Humeral Tray in Total Shoulder Arthroplasty
    NCT03726554
    Conditions:   Arthropathy of Shoulder Region;   Grossly Deficient Rotator Cuff;   Osteoarthritis of the Shoulder;   Rheumatoid Arthritis Without Humeral Metaphyseal Defects;   Post-Traumatic Arthritis
    Interventions:   Device: Comprehensive Reverse Porous Augmented Glenoid;   Device: Comprehensive Mini Humeral Tray
    Sponsor:   Zimmer Biomet
    Recruiting
  • Clinical Trial to Evaluate the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The RAINIER Study)
    NCT03633461
    Condition:   Dry Eye Disease
    Interventions:   Drug: OC-02;   Drug: Placebo
    Sponsor:   Oyster Point Pharma, Inc.
    Completed
  • A Trial for Treatment of Cancer Patients With Multiple Brain Metastases Undergoing Whole-Brain Radiotherapy
    NCT03608020
    Condition:   Multiple Brain Metastases
    Interventions:   Drug: BMX-001;   Radiation: Whole Brain Radiation Therapy
    Sponsors:   BioMimetix JV, LLC;   Duke Cancer Institute;   National Cancer Institute (NCI)
    Recruiting
  • Breast Cancer Recurrence Risk Counseling
    NCT03339518
    Condition:   Breast Cancer Female
    Interventions:   Behavioral: BRIM3 educational intervention;   Behavioral: Wait List
    Sponsors:   West Virginia University;   University of Kentucky
    Completed
  • Randomized Controlled Trial for Exparel Hip Fracture
    NCT03289858
    Condition:   Hip Fractures
    Interventions:   Drug: Exparel;   Drug: Sodium Chloride
    Sponsors:   University of Massachusetts, Worcester;   Orthopaedic Trauma Association;   University of Kentucky
    Completed
  • The Appeal and Impact of E-cigarettes in Smokers With SMI
    NCT03050853
    Conditions:   Tobacco Dependence;   Schizophrenia;   Bipolar Disorder;   Schizoaffective Disorder
    Intervention:   Behavioral: E-cigarette
    Sponsors:   Dartmouth-Hitchcock Medical Center;   Vinfen Corporation;   Centerstone Kentucky
    Recruiting
  • A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for the Treatment of Fuchs' Corneal Endothelial Dystrophy (FCED)
    NCT02653391
    Condition:   Fuchs' Corneal Endothelial Dystrophy (FCED)
    Interventions:   Drug: Elamipretide 1.0% Ophthalmic Solution;   Drug: Elamipretide 3.0% Ophthalmic Solution
    Sponsor:   Stealth BioTherapeutics Inc.
    Completed
  • A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye
    NCT02634853
    Condition:   Keratoconjunctivitis Sicca
    Interventions:   Drug: 1% Tavilermide Ophthalmic Solution;   Drug: Placebo Ophthalmic Solution
    Sponsor:   Mimetogen Pharmaceuticals USA, Inc.
    Completed
  • Evaluation of the Technical Success of IVUS Guided VCF Placement Using the LUMIFI™ With Crux® VCF System
    NCT02394912
    Conditions:   Pulmonary Embolism;   Deep Vein Thrombosis
    Intervention:   Device: vena cava filter implantation (LUMIFI with Crux VCF System)
    Sponsor:   Volcano Corporation
    Terminated
  • An Evaluation of Two PTSD Assessments in an Active Duty and Military Veteran Sample
    NCT04180930
    Condition:   Stress Disorders, Post-Traumatic
    Interventions:   Diagnostic Test: CAPS-5;   Diagnostic Test: PSSI-5;   Diagnostic Test: CAPS-IV
    Sponsor:   U.S. Army Medical Research and Development Command
    Recruiting
  • Characterize the Nicotine Uptake and Subjective Effects With Use of JUUL Electronic Nicotine Delivery Systems
    NCT04123041
    Conditions:   Electronic Cigarette Use;   Tobacco Smoking
    Intervention:   Other: JUUL ENDS, Combustible cigarette, comparator e-cigarette, Nicorette gum
    Sponsor:   Juul Labs, Inc.
    Enrolling by invitation
  • A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer
    NCT03899636
    Condition:   Stage III Pancreatic Cancer
    Interventions:   Drug: Modified FOLFIRINOX Regimen;   Device: NanoKnife System
    Sponsor:   Angiodynamics, Inc.
    Recruiting
  • Performance of MOTO Medial® Unicompartmental Knee Arthroplasty
    NCT03211663
    Conditions:   Knee Osteoarthritis;   Knee Arthritis;   Knee Pain Chronic
    Intervention:   Device: MOTO Medial® UKA
    Sponsor:   Medacta USA
    Recruiting
  • Induction of Donor Specific Tolerance in Recipients of Live Donor Kidney Allografts by Donor Stem Cell Infusion
    NCT00498160
    Condition:   Renal Failure
    Intervention:   Biological: Enriched Hematopoetic Stem Cell Infusion
    Sponsors:   University of Louisville;   Northwestern University
    Active, not recruiting
  • The Prevalence of White Spot Lesions During Orthodontic Treatment With Fixed Appliances
    NCT04186065
    Condition:   Dental Caries
    Intervention:  
    Sponsor:   Hiroko Nagaoka
    Enrolling by invitation
  • Conquering Feared Foods Study
    NCT04155788
    Conditions:   Eating Disorder Symptom;   Fear
    Intervention:   Behavioral: Food Exposure
    Sponsor:   University of Louisville
    Recruiting
  • Adrenergic Cholinergic Enteric Measures/Mapping
    NCT04013282
    Condition:   Obesity
    Intervention:  
    Sponsor:   University of Louisville
    Recruiting
  • Elbow Arthroscopy Data Analysis
    NCT03656185
    Conditions:   Osteoarthritis Elbow Left;   Osteoarthritis Elbow Right;   Lateral Epicondylitis, Left Elbow;   Lateral Epicondylitis, Right Elbow;   Plica Syndromes;   Osteochondritis Dissecans
    Intervention:  
    Sponsor:   The Orthopaedic Research & Innovation Foundation
    Active, not recruiting
  • Telemedicine-based, Multidisciplinary-team, Intervention to Reduce Unnecessary Hospitalizations
    NCT03378245
    Conditions:   Dementia Alzheimers;   Disruptive Behavior
    Intervention:   Behavioral: Behavioral modification and education on pharmacologic treatments.
    Sponsor:   Richard Ronan Murphy
    Suspended
  • A Multiple Dose Opioid Challenge Study
    NCT02611752
    Condition:   Moderate or Severe Opioid Use Disorder
    Intervention:   Drug: CAM2038
    Sponsor:   Braeburn Pharmaceuticals
    Completed
  • Communities Helping the Hearing of Infants by Reaching Parents
    NCT03875339
    Condition:   Congenital Hearing Loss
    Intervention:   Behavioral: Navigator Guidance
    Sponsors:   University of Kentucky;   National Institute on Deafness and Other Communication Disorders (NIDCD);   National Institutes of Health (NIH)
    Active, not recruiting
  • A Clinical Study to Evaluate the Clinical Performance and Safety of LiquiBand FIX8® Versus AbsorbaTack™ for Hernia Mesh Fixation and Peritoneal Closure in Groin Hernia Repair
    NCT04009213
    Conditions:   Hernia;   Inguinal Hernia;   Femoral Hernia;   Groin Hernia
    Interventions:   Device: LiquiBand FIX8®;   Device: AbsorbaTack™
    Sponsor:   Advanced Medical Solutions Ltd.
    Recruiting
  • Birinapant and Intensity Modulated Re-Irradiation Therapy in Treating Patients With Locally Recurrent Head and Neck Squamous Cell Carcinoma
    NCT03803774
    Condition:   Recurrent Head and Neck Squamous Cell Carcinoma
    Interventions:   Drug: Birinapant;   Radiation: Intensity-Modulated Radiation Therapy
    Sponsor:   National Cancer Institute (NCI)
    Recruiting
  • Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
    NCT03794583
    Conditions:   Pulmonary Hypertension;   Chronic Obstructive Pulmonary Disease
    Intervention:   Drug: Inhaled treprostinil solution
    Sponsors:   United Therapeutics;   Lung Biotechnology PBC
    Enrolling by invitation
  • Harnessing Neuroplasticity to Enhance Functional Recovery During Chronic Recovery From Upper Extremity Nerve Repair
    NCT03610763
    Conditions:   Hand Transplantation;   Peripheral Nerve Injuries;   Neurologic Rehabilitation
    Interventions:   Device: Transcranial Direct Current Stimulation;   Behavioral: Modified Constraint Induced Movement Therapy
    Sponsors:   University of Missouri-Columbia;   Washington University School of Medicine;   Christine M. Kleinert Institute for Hand and Microsurgery
    Recruiting
  • Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract
    NCT03496467
    Conditions:   Pain;   Inflammation
    Interventions:   Combination Product: Nepafenac PPDS;   Combination Product: Placebo PPDS
    Sponsor:   Mati Therapeutics Inc.
    Completed
  • An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib
    NCT02955940
    Conditions:   Pancreatic Cancer;   Colorectal Cancer (CRC);   Breast Cancer;   Lung Cancer
    Interventions:   Drug: Ruxolitinib;   Drug: Capecitabine;   Drug: Regorafenib
    Sponsor:   Incyte Corporation
    Enrolling by invitation
  • Collection of Serum Samples From Children and Older Adults Receiving the 2019-2020 Formulations of Fluzone® Quadrivalent and Fluzone® High-Dose Influenza Vaccines, Respectively
    NCT04109222
    Condition:   Influenza
    Interventions:   Biological: Fluzone Quadrivalent vaccine, 2019-2020 formulation;   Biological: Fluzone High-Dose vaccine, 2019-2020 formulation
    Sponsor:   Sanofi Pasteur, a Sanofi Company
    Recruiting
  • Journey of Hope in Appalachia: Supporting Resilience in the Region's Youth
    NCT04096937
    Condition:   Adverse Childhood Experiences
    Intervention:   Other: Focus groups
    Sponsors:   Gia Mudd;   West Virginia University
    Not yet recruiting
  • Phase I Trial HIPEC With Nal-irinotecan
    NCT04088786
    Conditions:   Peritoneal Cancer;   Pseudomyxoma Peritonei;   Mucinous Adenocarcinoma;   Mucinous Tumor;   Colorectal Cancer;   Gastric Cancer;   Primary Peritoneal Carcinoma;   Mesothelioma
    Intervention:   Drug: nanoliposomal irinotecan
    Sponsors:   Stony Brook University;   University of Kentucky;   University of San Diego
    Recruiting
  • Copanlisib Hydrochloride and Nivolumab in Treating Patients With Recurrent or Refractory Diffuse Large B-cell Lymphoma or Primary Mediastinal Large B-cell Lymphoma
    NCT03484819
    Conditions:   Recurrent Diffuse Large B-Cell Lymphoma;   Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma;   Refractory Diffuse Large B-Cell Lymphoma;   Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma
    Interventions:   Drug: Copanlisib;   Drug: Copanlisib Hydrochloride;   Biological: Nivolumab
    Sponsor:   National Cancer Institute (NCI)
    Recruiting
  • Pharmacokinetic Single Dose Study of Oral Lasmiditan in Participants With Normal and Impaired Hepatic Function
    NCT03040479
    Condition:   Migraine
    Intervention:   Drug: lasmiditan 200 mg
    Sponsors:   Eli Lilly and Company;   Algorithme Pharma Inc;   CoLucid Pharmaceuticals
    Completed
  • Implementation of Prolonged Exposure in the Military
    NCT02982538
    Condition:   PTSD
    Interventions:   Behavioral: Extended Training in Prolonged Exposure Therapy for PTSD;   Behavioral: Standard Training in Prolonged Exposure Therapy for PTSD
    Sponsors:   University of Pennsylvania;   University of Texas
    Active, not recruiting
  • A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer
    NCT03899649
    Condition:   Stage III Pancreatic Cancer
    Interventions:   Drug: SOC;   Device: NanoKnife System
    Sponsor:   Angiodynamics, Inc.
    Recruiting
  • Bio2 Vitrium® Cervical Cage in Anterior Cervical Discectomy and Fusion
    NCT03828136
    Condition:   Symptomatic Cervical Disc Disease
    Interventions:   Device: Bio2 Vitrium® Cervical Interbody Device;   Device: Allograft Ring or Block
    Sponsors:   Bio2 Technologies;   Musculoskeletal Clinical Regulatory Advisers
    Recruiting
  • Continued Access to PREVAIL (CAP2) - WATCHMAN Left Atrial Appendage (LAA) Closure Technology
    NCT01760291
    Condition:   Atrial Fibrillation
    Intervention:   Device: WATCHMAN LAA Closure Technology
    Sponsor:   Boston Scientific Corporation
    Completed
  • Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies
    NCT01419704
    Conditions:   Anemia, Sickle Cell;   Complex and Transfusion-dependent Hemoglobinopathies;   Thalassemia;   Diamond-Blackfan Anemia;   Bone Marrow Failure Syndromes;   Alpha-Thalassemia;   Beta-Thalassemia
    Intervention:   Biological: Enriched Hematopoetic Stem Cell Infusion
    Sponsors:   University of Louisville;   Duke University
    Suspended
  • Telepharmacy Robotic Medicine Delivery Unit "TRMDU" Assessment
    NCT01007006
    Conditions:   Traumatic Brain Injury;   Posttraumatic Stress Disorders;   Trauma;   Combat Disorders;   Pain
    Intervention:   Device: TMRDU
    Sponsors:   University of Illinois at Chicago;   U.S. Army Medical Research and Development Command
    Withdrawn
  • Safety and Efficacy of Ophthalmic Phentolamine Mesylate to Reverse Pharmacologically Induced Mydriasis
    NCT04024891
    Conditions:   Mydriasis;   Dilation
    Interventions:   Drug: Phentolamine Mesylate Ophthalmic Solution 1%;   Other: Phentolamine Mesylate Ophthalmic Solution Vehicle (Placebo)
    Sponsor:   Ocuphire Pharma, Inc.
    Completed
  • A Phase 1/2, Randomized, Placebo-controlled, Observer-blinded Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Adults 18 To 49 Years Of Age
    NCT03170609
    Condition:   Group B Streptococcal Infections
    Interventions:   Biological: Multivalent group B streptococcus vaccine;   Biological: Placebo
    Sponsor:   Pfizer
    Completed
  • Safety and Immunogenicity of the Bris10 M2SR and Sing2016 M2SR H3N2 Monovalent Influenza Vaccines
    NCT03999554
    Condition:   Influenza A
    Interventions:   Biological: LD Sing2016 M2SR H3N2 influenza vaccine;   Biological: MD Sing2016 M2SR H3N2 influenza vaccine;   Biological: HD Sing2016 M2SR H3N2 influenza vaccine;   Biological: LD Bris10 M2SR H3N2 influenza vaccine;   Other: Placebo
    Sponsor:   FluGen Inc
    Recruiting
  • Panblok H7 Vaccine Adjuvanted With AS03 or MF59
    NCT03283319
    Condition:   Influenza, Human
    Interventions:   Biological: 3.75 ug Panblok H7;   Biological: 7.5 ug Panblok H7;   Biological: 15 ug Panblok H7;   Biological: MF59;   Biological: AS03
    Sponsors:   Biomedical Advanced Research and Development Authority;   Rho, Inc.
    Completed
  • Safety and Immunogenicity of Fluzone® Quadrivalent, Flublok® Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines, 2018-2019 Formulations
    NCT03617523
    Condition:   Influenza
    Interventions:   Biological: Fluzone Quadrivalent vaccine, 2018-2019 formulation;   Biological: Flublok Quadrivalent vaccine, 2018-2019 formulation;   Biological: Fluzone High-Dose vaccine, 2018-2019 formulation
    Sponsor:   Sanofi Pasteur, a Sanofi Company
    Completed
  • A Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Allergic Conjunctivitis
    NCT04050865
    Condition:   Allergic Conjunctivitis
    Interventions:   Drug: Dexamethasone, 0.4mg;   Device: Placebo plug with no drug
    Sponsor:   Ocular Therapeutix, Inc.
    Recruiting
  • A Study of Nivolumab +/- Nab-paclitaxel in Non-small Cell Lung Cancer
    NCT02967133
    Conditions:   Non-Small-Cell Lung Cancer Metastatic;   Non-Small Cell Carcinoma of Lung, TNM Stage 4;   Nonsmall Cell Lung Cancer;   Non Small Cell Lung Cancer Recurrent
    Interventions:   Drug: Nivolumab;   Drug: nab-paclitaxel
    Sponsors:   Alliance Foundation Trials, LLC.;   Celgene Corporation;   Bristol-Myers Squibb
    Active, not recruiting
  • Phase 1 Study of BXQ-350 in Adult Patients With Advanced Solid Tumors
    NCT02859857
    Condition:   Neoplasms
    Intervention:   Drug: BXQ-350
    Sponsors:   Bexion Pharmaceuticals, Inc.;   CTI Clinical Trial and Consulting Services
    Active, not recruiting
  • Onalespib and Paclitaxel in Treating Patients With Advanced Triple Negative Breast Cancer
    NCT02474173
    Conditions:   Advanced Breast Carcinoma;   Metastatic Breast Carcinoma;   Stage III Breast Cancer AJCC v7;   Stage IIIA Breast Cancer AJCC v7;   Stage IIIB Breast Cancer AJCC v7;   Stage IIIC Breast Cancer AJCC v7;   Stage IV Breast Cancer AJCC v6 and v7;   Triple-Negative Breast Carcinoma
    Interventions:   Other: Laboratory Biomarker Analysis;   Drug: Onalespib;   Drug: Onalespib Lactate;   Drug: Paclitaxel;   Other: Pharmacological Study
    Sponsor:   National Cancer Institute (NCI)
    Active, not recruiting
  • Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer
    NCT03914300
    Conditions:   Differentiated Thyroid Gland Carcinoma;   Follicular Variant Thyroid Gland Papillary Carcinoma;   Poorly Differentiated Thyroid Gland Carcinoma;   Progressive Thyroid Carcinoma;   Refractory Thyroid Gland Carcinoma;   Tall Cell Variant Thyroid Gland Papillary Carcinoma;   Thyroid Gland Follicular Carcinoma;   Thyroid Gland Hurthle Cell Carcinoma;   Thyroid Gland Papillary Carcinoma
    Interventions:   Drug: Cabozantinib;   Drug: Cabozantinib S-malate;   Biological: Ipilimumab;   Biological: Nivolumab
    Sponsor:   National Cancer Institute (NCI)
    Recruiting
  • Pre-Operative Cemiplimab Administered Intralesionally for Patients With Recurrent Cutaneous Squamous Cell Carcinoma
    NCT03889912
    Condition:   Cutaneous Squamous Cell Carcinoma
    Intervention:   Drug: Cemiplimab
    Sponsors:   Regeneron Pharmaceuticals;   Sanofi
    Recruiting
  • Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies
    NCT00777231
    Condition:   Sickle Cell Disease
    Intervention:   Biological: Enriched Hematopoetic Stem Cell Infusion
    Sponsors:   University of Louisville;   Duke University;   St. Christopher's Hospital for Children;   The Western Pennsylvania Hospital;   University of Florida;   Medical College of Pennsylvania Hospital;   Hahnemann University Hospital
    Completed
  • Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-C
    NCT03531905
    Conditions:   Diabetes;   Diabetes Mellitus, Type 2;   Cholesterolemia
    Interventions:   Drug: Bempedoic acid + Ezetimibe FDC Oral Tablet;   Drug: Ezetimibe 10Mg Oral Tablet;   Drug: Placebo Oral Tablet;   Drug: Placebo oral capsule
    Sponsor:   Esperion Therapeutics
    Completed
  • Lumbar Discectomy Control Study, Risk Factors for Reherniation
    NCT02477176
    Condition:   Lumbar Spine Disc Herniation
    Intervention:   Other: Discectomy
    Sponsor:   Intrinsic Therapeutics
    Active, not recruiting
  • Evaluating Bactisure Wound Lavage in Orthopedic Wounds
    NCT03192124
    Condition:   Infection of Total Knee Joint Prosthesis
    Intervention:   Device: Bactisure
    Sponsor:   Zimmer Biomet
    Completed
  • The PATH Home Trial: A Comparative Effectiveness Study of Peripartum Opioid Use Disorder in Rural Kentucky
    NCT03725332
    Condition:   Neonatal Abstinence Syndrome
    Interventions:   Behavioral: Telemedicine;   Behavioral: Group Care
    Sponsors:   Wendy F Hansen;   Patient-Centered Outcomes Research Institute
    Recruiting
  • A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)
    NCT02637856
    Condition:   Multiple Sclerosis, Relapsing-Remitting
    Intervention:   Drug: Ocrelizumab
    Sponsor:   Genentech, Inc.
    Active, not recruiting
  • HEALing Communities Study
    NCT04111939
    Condition:   Opioid Use Disorder (OUD)
    Interventions:   Other: Communities That HEAL;   Other: Wait-list control
    Sponsors:   RTI International;   Boston Medical Center;   Columbia University;   Ohio State University;   University of Kentucky;   National Institute on Drug Abuse (NIDA);   Substance Abuse and Mental Health Services Administration (SAMHSA)
    Active, not recruiting
  • Retrospective Review of the Cook Biodesign® Fistula Plug to Treat Anorectal Fistulas
    NCT03321266
    Condition:   Anorectal Fistula
    Intervention:   Device: Cook Biodesign® Fistula Plug
    Sponsor:   Cook Group Incorporated
    Completed
  • A Phase 1/2 Open-Label, Dose Escalation Study to Determine the Optimal Dose, Safety, and Activity of AAV2hAQP1 in Subjects With Radiation-Induced Parotid Gland Hypofunction and Xerostomia
    NCT04043104
    Conditions:   Radiation-Induced Parotid Gland Hypofunction;   Xerostomia Due to Radiotherapy;   Head and Neck Cancer
    Intervention:   Drug: intra-parotid administration of AAV2hAQP1
    Sponsor:   MeiraGTx UK II Ltd
    Recruiting
  • Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial
    NCT03500328
    Condition:   Multiple Sclerosis, Relapsing-Remitting
    Intervention:   Other: Early Aggressive Therapy or Traditional Therapy
    Sponsors:   Johns Hopkins University;   Patient-Centered Outcomes Research Institute
    Recruiting
  • AMPLATZER PFO Occluder Post Approval Study
    NCT03309332
    Conditions:   Stroke;   Patent Foramen Ovale
    Intervention:   Device: AMPLATZER™ PFO Occluder
    Sponsor:   Abbott Medical Devices
    Recruiting
  • A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain
    NCT03213457
    Condition:   Endometriosis
    Interventions:   Drug: Estradiol/Norethindrone Acetate;   Other: Placebo for Elagolix;   Drug: Elagolix;   Other: Placebo for E2/NETA
    Sponsor:   AbbVie
    Active, not recruiting
  • Safety and Efficacy Study of PRV111 in Subjects With Oral Squamous Cell Carcinoma
    NCT03502148
    Condition:   Oral Squamous Cell Carcinoma
    Intervention:   Drug: PRV111 (Cisplatin Transmucosal System)
    Sponsor:   Privo Technologies
    Recruiting
  • A Study to Evaluate Safety and Efficacy of SAGE-547 in Participants With Moderate Postpartum Depression (547-PPD-202C)
    NCT02942017
    Condition:   Postpartum Depression
    Interventions:   Drug: Placebo;   Drug: SAGE-547 90 μg/kg/h
    Sponsor:   Sage Therapeutics
    Completed
  • A Study to Evaluate Efficacy and Safety of SAGE-547 in Participants With Severe Postpartum Depression (547-PPD-202B)
    NCT02942004
    Condition:   Postpartum Depression
    Interventions:   Drug: Placebo;   Drug: SAGE-547 60 μg/kg/h;   Drug: SAGE-547 90 μg/kg/h
    Sponsor:   Sage Therapeutics
    Completed
  • IMplementation of an RCT to imProve Treatment With Oral AntiCoagulanTs in Patients With Atrial Fibrillation
    NCT03259373
    Conditions:   Atrial Fibrillation;   Stroke
    Interventions:   Behavioral: Early Intervention;   Behavioral: Delayed Intervention
    Sponsors:   Harvard Pilgrim Health Care;   Duke Clinical Research Institute;   HealthCore, Inc.;   Clinical Trials Transformation Initiative;   Humana, Inc. - Comprehensive Health Insights;   Aetna, Inc.;   OptumInsight Life Sciences, Inc.;   Food and Drug Administration (FDA)
    Active, not recruiting
  • A Proof of Concept Study to Evaluate CN-105 in ICH Patients
    NCT03168581
    Condition:   Intracerebral Hemorrhage
    Intervention:   Drug: CN-105
    Sponsors:   AegisCN LLC;   Duke Clinical Research Institute;   PharPoint Research, Inc.
    Completed
  • Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution in Subjects With Dry Eye Syndrome
    NCT04147650
    Conditions:   Dry Eye Syndrome;   Keratoconjunctivitis Sicca
    Interventions:   Drug: 0.05% Voclosporin Ophthalmic Solution (VOS);   Drug: 0.10% VOS;   Drug: 0.20% VOS;   Drug: Vehicle Ophthalmic Solution
    Sponsor:   Aurinia Pharmaceuticals Inc.
    Recruiting
  • A Phase 2 Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention
    NCT01952574
    Condition:   Migraine
    Interventions:   Drug: Erenumab;   Drug: Placebo
    Sponsor:   Amgen
    Completed
  • A Study of Retreatment With Brentuximab Vedotin in Subjects With Classic Hodgkin Lymphoma or CD30-expressing Peripheral T Cell Lymphoma
    NCT03947255
    Conditions:   Hodgkin Lymphoma;   Peripheral T Cell Lymphoma;   Anaplastic Large Cell Lymphoma
    Intervention:   Drug: brentuximab vedotin
    Sponsor:   Seattle Genetics, Inc.
    Recruiting
  • A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis
    NCT01412333
    Condition:   Relapsing Multiple Sclerosis
    Interventions:   Drug: Interferon beta-1a;   Drug: Ocrelizumab-matching placebo;   Drug: Ocrelizumab;   Drug: Interferon beta-1a-matching placebo
    Sponsor:   Hoffmann-La Roche
    Active, not recruiting
  • A Two-year Open-label Extension Study of Ganaxolone in Patients With Drug-resistant Partial-onset Seizures
    NCT02519439
    Condition:   Drug Resistant Partial Onset Seizure
    Intervention:   Drug: ganaxolone
    Sponsor:   Marinus Pharmaceuticals
    Terminated
  • Legion Primary S & E
    NCT04040985
    Conditions:   Osteo Arthritis Knee;   Total Knee Replacement
    Intervention:   Procedure: Total Knee Arthroplasty using Legion Total Knee System
    Sponsor:   Smith & Nephew, Inc.
    Active, not recruiting
  • Study of GBR 1302 (CD3 Bispecific Ab) in HER2-positive Metastatic Breast Cancer
    NCT03983395
    Condition:   Breast Cancer
    Interventions:   Biological: GBR 1302 250 ng/kg;   Biological: GBR 1302 325 ng/kg;   Biological: GBR 1302 325 ng/kg-D1;425 ng/kg -D8,D15,D22;   Biological: GBR 1302 325 ng/kg-D1;550 ng/kg -D8,D15,D22;   Biological: GBR1302 325ng/kgD1;550 ng/kg D8;700 ng/kgD15,22;   Biological: GBR1302 325ng/kg D1;550 ng/kg D8;900 ng/kg D15,22;   Biological: GBR1302 escalating doses,1200 ng/kg D15,22;   Biological: GBR1302 at the MTD and/or RP2D dose
    Sponsor:   Glenmark Pharmaceuticals S.A.
    Recruiting

Popular Now

  • Privacy Policy
  • Ad and Cookie Policy
  • Infringement Policy
  • Terms of Use
  • Email Policy
  • Contact Us
  • Post Clinical Trials
  • Join Clinical Trials
  • Volunteer Login
  • Recruiters Login
  • Frequently Asked Questions
  • Blog
  • Find Clinical Trials
  • Find Volunteers
  • Trials by Category
  • Trials by Location
  • Volunteers by Category
  • Volunteers by Location
All clinical trials are registered and certified with clinicaltrials.gov. Data via U.S. National Library of Medicine,U.S. National Institutes of Health, U.S. Department of Health & Human Services. JoinClinicaltrials.com (Aunica Media llc) is a free resource that provides individuals and companies with information regarding clinical trials that are being conducted nationwide. Aunica Media llc does not conduct clinical trials nor endorses them. Please consult your doctor or physician before participating. And Ye shall know the truth, and the truth shall make you free
©2001-2019 Aunica Media LLC